Chronic Riluzole Treatment Increases Glucose Metabolism in Rat Prefrontal Cortex and Hippocampus

Golam MI Chowdhury,Mounira Banasr,Robin A de Graaf,Douglas L Rothman,Kevin L Behar,Gerard Sanacora

DOI: https://doi.org/10.1038/jcbfm.2008.78

2008-07-16

Abstract:Riluzole is believed to modulate glutamatergic function by reducing glutamate release and facilitating astroglial uptake. We measured 13 C labeling in metabolites in prefrontal cortex and hippocampus during a 10 mins infusion of [1- 13 C]glucose in urethane anesthetized rats treated with riluzole (21 days, 4 mg/kg per day, i.p.) or saline. Total and 13 C concentrations of metabolites were determined in extracts using 1 H-[ 13 C] NMR spectroscopy. In prefrontal cortex ( P < 0.05) and hippocampus ( P < 0.05) riluzole increased 13 C labeling over saline in glutamate-C4 (to 112% and 130%), GABA-C2 (to 142% and 171%), and glutamine-C4 (to 118% and 233%) without affecting total metabolite levels ( P > 0.2). Our findings indicate that contrary to expectation chronic riluzole enhanced glucose oxidative metabolism and glutamate/glutamine cycling.

neurosciences,endocrinology & metabolism,hematology